Trial Profile
Retrospective study of Orlistat on reduction of weight in obese Korean patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Dec 2015
Price :
$35
*
At a glance
- Drugs Orlistat (Primary)
- Indications Obesity
- Focus Pharmacodynamics; Therapeutic Use
- 06 Dec 2015 New trial record